Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2004-10-06
2011-11-22
Dejong, Eric S (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C435S006120, C435S069100, C703S011000
Reexamination Certificate
active
08065093
ABSTRACT:
The present invention provides methods, systems and compositions for predicting disease susceptibility in a patient. In some embodiments, methods for the classification, prognosis, and diagnosis of cancers are provided. In other embodiments, the present invention provides statistical methods for building a gene-expression-based classifier that may be employed for predicting disease susceptibility in a patient, for classifying carcinomas, and for the prognosis of clinical outcomes.
REFERENCES:
patent: 6208983 (2001-03-01), Parra et al.
patent: 6306087 (2001-10-01), Barnhill et al.
patent: 6468476 (2002-10-01), Friend et al.
patent: 6714925 (2004-03-01), Barnhill et al.
patent: 6757412 (2004-06-01), Parsons et al.
patent: 2004/0058340 (2004-03-01), Dai et al.
patent: WO 2004/065583 (2004-08-01), None
GenBank Accession for AW299538 [online], [retrieved Mar. 15, 2008] Retrieved from the internt <http://www.ncbi.nlm.nih.gov/sites/entrez?term=AW299538&cmd=Search&db=nucest&QueryKey=1>.
GenBank Accession for R73030 [online], [retrieved Mar. 15, 2008 from the internet <http://www.ncbi.nlm.nih.gov/sites/entrez?term=R73030&cmd=Search&db=nucest&QueryKey=5>.
GenBank Accession for BG271923 [online], [retrieved from the internet <http://www.ncbi.nlm.nih.gov/sites/entrez?term=Bg271923&cmd=Search&db=nucest&QueryKey=8>.
Nielsen et al.,Science, 254: 1497-1500 (1991).
Neilsen,Curr. Opin. Biotechnol., 10:71-75 (1999).
Bergh et al.,Nat Med, 1:1029-1034 (1995).
Elston, C. et al.,Histopathology, 19:403-410 (1991).
Cattoretti, G. et al.,Int J. Cancer, 41:178-183 (1988).
Isola, J. et al.,J. Natl Cancer Inst, 84:1109-1114 (1992).
Andersen, T.I. et al.,Br J Cancer, 68:540-548 (1993).
Bhargava, V. et al.,Mod Pathol, 7:361-368 (1994).
Dudoit, S. et al.,Journal of the American Statistical Association, 97:77-87 (2002).
el-Deiry, W.S. et al.,Nat Genet, 1:45-49 (1992).
Miller et al., “An expression signature for p53 status in human breast cancer patients predicts mutation status, transcriptional effects, and patient survival,”Proc. Natl. Acad. Sci. USA, 102(38): 13550-13555 (2005).
Shepard et al., “A zebrafish bmyb mutations causes genome instability and increased cancer susceptibility,”Proc. Natl. Acad. Sci. USA, 102(37): 13194-13199 (2005).
Okada et al., “Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma,”FEBS Letters, 555: 583-590 (2003).
Nicoll et al., “Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer,”British Journal of Cancer, 85(12): 1878-1882 (2001).
Qiu et al., “Down-regulation of growth arrest DNA damage-inducible gene 45β expression is associated with human hapatocellular carcinoma,”American Journal of Pathology, 162(6): 1961-1974 (2003).
Zhang et al., “Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors,”International Journal of Oncology, 20: 1145-1150 (2002).
Chevillard et al., “Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses of breast cancer patients treated with primary chemotherapy or radiotherapy,”Clinical Cancer Research, 3: 2471-2478 (1997).
Aubele et al., “Genetic alteration in presumptive precursor lesions of breast carcinomas,”Analytical Cellular Pathology, 24: 69-76 (2002).
Sambrook et al.,Molecular Cloning: A Laboratory Manual, 3rdedition (2001).
Sambrook et al.,Molecular Cloning: A Laboratory Manual, 2ndedition (1998).
Anderson,Nucleic Acid Hybridization, 1stedition (1999).
Egyhazi, S. et al.,Clin Chem, 50:975-976 (2004).
Sorlie, T. et al.,Proc Natl Acad Sci USA, 100: 8418-8423 (2003).
Chen, X. et al.,Mol Biol Cell, 13:1929-1939 (2002).
Vega, V.B. et at.,Nucleic Acids Res, 32:257-260 (2004).
Kel, A.E. et al.,Nucleic Acid Res, 31:3576-3579 (2003).
Berns, E.M. et al.,Cancer Res, 60:2155-2162 (2000).
van't Veer, L.J. et al.,Nature, 415:530-536 (2002).
Forozan, F., et al.,Cancer Res, 60:4519-4525 (2000).
Tanner, M.M. et al.,Clin Cancer Res, 6:1833-1839 (2000).
Krop, I.E. et al.,Proc Natl Acad Sci USA, 98:9796-9801 (2001).
Setubal et al.,Intro to Computational Bio Methods, (1997).
Salzberg et al.,Computational Methods in Molecular Bio, (1998).
Rashidi et al.,Bioinformatics Basics: Appl in Bio Science and Medicine, (2000).
Oulette et al.,A Practical Guide for Analysis of Genes and Proteins, (2001).
Ramaswamy et al.,PNAS, 98: 15149-15154 (2001).
Lee et al., “Biochemical evaluation of patients with breast cancer,”J. Surg. Oncol., 19(4): 197-200 (1982).
DeVita et al.,Cancer: Principles&Practice of Oncology, 5th Edition, 1997, p. 1569.
Affymetrix GeneChip Human Genome U133 Array Set HG-U133A, GEO, Mar. 11, 2002, XP002361324, abstract.
Raschella et al., “Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification,” Cancer Research, 1999; 59(14): 3365-3368.
Amatschek et al., “Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific gene,” Cancer Research, 2004; 64(3): 844-856.
Sala et al., “B-Myb protein in cellular proliferation, transcription control, and cancer: latest developments,” Journal of Cellular Physiology, 1999; 179(3): 245-250.
George Joshy
Miller Lance D.
Vega Vinsensius B.
Agency For Science, Technology And Research
Barnes & Thornburg LLP
Dejong Eric S
LandOfFree
Methods, systems, and compositions for classification,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods, systems, and compositions for classification,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods, systems, and compositions for classification,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4297118